UnitedHealth Group, Eli Lilly and Company, and Walmart are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares in companies that provide ...

I started using Ozempic three months ago. My decision to use the drug to lose weight wasn’t impulsive. I had tried multiple ...

Got “Ozempic face”? It’s because your skin can’t keep up with the rapid weight loss, cosmetic doctor Nyla Raja tells William ...

A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and Mounjaro — that have ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

The proposal would have enabled more Americans to afford new medications in the GLP-1 class that have been shown to reduce weight.

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...